SCHEMBL7186161

SCHEMBL7186161

CNc1ccc(C(=O)/C=C/c2c(OC)ccc(C)c2OC)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.55
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 2/20 0.45
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
KRAS P01116 4/20 0.45
MAOA P21397 2/20 0.44
ALDH1A1 P00352 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186165 1.00 ABCG2 (0.55) ABCG2CA1CA2CYP1A2CYP3A4
SCHEMBL7180084 0.86 CAPN1 (0.59) ABCG2CA1CA2MEN1KMT2A
SCHEMBL7180079 0.86 CAPN1 (0.59) ABCG2CA1CA2MEN1KMT2A
SCHEMBL7186266 0.85 CA1 (0.62) ABCG2CA1CA2CYP1A2CYP3A4
SCHEMBL7186261 0.85 CA1 (0.62) ABCG2CA1CA2CYP1A2CYP3A4
SCHEMBL7184265 0.84 ABCG2 (0.51) ABCG2CA1CA2CYP1A2CYP3A4
SCHEMBL7184271 0.84 ABCG2 (0.51) ABCG2CA1CA2CYP1A2CYP3A4
SCHEMBL7191260 0.83 CYP1A1 (0.46) ABCG2CYP1A2MAPTNPC1RAB9A
SCHEMBL7187821 0.83 ABCG2 (0.40) ABCG2CA1CA2CYP3A4MEN1
SCHEMBL7191264 0.83 CYP1A1 (0.46) ABCG2CYP1A2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed